4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
bear and bull markets, with the growth-fueled Nasdaq Composite (NASDAQINDEX: ^IXIC) enduring the wildest swings. Despite losing 33% of its value during the 2022 bear market, the innovation-powered Nasdaq Composite has gained 49% since the beginning of 2023 and firmly established that it's in a new, albeit young, bull market The great thing about bull markets is that amazing deals can always be uncovered. Regardless of whether the Nasdaq Composite is reaching new heights or has, in this instance, pulled back 5% from its record-closing high, opportunistic investors willing to put in the work can still locate growth stocks at a discount. Here are four dominant growth stocks you'll regret not buying in the new Nasdaq bull market. Intel The first sensational growth stock that's begging to be bought in this relatively young Nasdaq bull market is semiconductor stalwart Intel (NASDAQ: INTC) Though Intel doesn't fit the traditional definition of a growth stock -- sales are forecast
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- BioMarin Pharmaceutical to lay off 170 employees [Seeking Alpha]Seeking Alpha
- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $113.00 price target on the stock.MarketBeat
- BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV [Yahoo! Finance]Yahoo! Finance
- BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NVPR Newswire
- New Data for BioMarin's VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting [Yahoo! Finance]Yahoo! Finance
BMRN
Earnings
- 4/24/24 - Beat
BMRN
Sec Filings
- 5/14/24 - Form 8-K
- 5/13/24 - Form 4
- 5/10/24 - Form 144
- BMRN's page on the SEC website